Comparative Efficacy Of 4 mg VS. 8 mg Submucosal Dexamethasone In Postoperative Pain Management After Dental Implant Surgery: A Randomized Double-Blind Controlled Clinical Trial
Recruiting · NCT07413055 · Interventional (participants receive a specific treatment) · Lead sponsor: Oman Ministry of Health
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This study aims to compare the effectiveness of 4mg and 8mg dexamethasone administered submucosally in reducing postoperative pain after dental implant surgery. Participants will be randomly assigned to receive either 4mg dexamethasone, 8mg dexamethasone, or a placebo (normal saline) at the surgical site. Later, postoperative pain will be assessed using a Visual Analog Scale at 6 hours after the surgery and daily for the next 6 days. Also the number of pain-relief tablets consumed after the surgery will be recorded. Preoperative anxiety will be assessed using Generalized Anxiety Disorder-7 (GAD-7) questionnaire to assess its association with postoperative pain scores. The results of this study will help determine the optimal dose of dexamethasone that is effective for postoperative pain control following dental implant surgery.
Who can take part
Inclusion criteria
- Males \& females
- Age range (21-80)
- ASA I \& II according to (American Society of Anesthesiologists) classification
- Single tooth implant
- Type 3 \& type 4 implant placement timing (Chen and Buser, 2009)
Exclusion criteria
- Any known allergy to any medications which will be used in the study
- Smokers/ Alcoholics
- Pregnant and lactating women
- Bone augmentation/ sinus lifting required during the surgery
- The need of antibiotic prophylaxis
Where it is running
1 location listed.
- Al Nahdha Hospital - Muscat, Oman